Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

GSK's COPD treatment Encruse Ellipta gets Japanese approval GlaxoSmithKline (GSK) has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for Encruse Ellipta (umeclidinium) for the relief of various symptoms due to airway obstruction with chronic obstructive pulmonary diseases (COPD). Drug Research > Drug Delivery > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

The Medicines Company gets FDA approval for new formulation of Minocin for injection
By PBR Staff Writer
The Medicines Company (MDCO) has received approval from the US Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) for a new formulation of Minocin (minocycline) for Injection.
News
Merck submits sBLA to FDA for Keytruda to treat NSCLC
By PBR Staff Writer
Merck has submitted a supplemental biologics license application (sBLA) to the US Food and Drug Administration (FDA) seeking approval for its anti-PD-1 therapy, Keytruda (pembrolizumab), to treat advanced non-small cell lung cancer (NSCLC).
News

Drug Discovery & Development

Lilly reports positive results from Phase III trial of ixekizumab to treat psoriatic arthritis
By PBR Staff Writer
Eli Lilly and Company has announced that a Phase III trial (SPIRIT-P1) of its investigational medicine, ixekizumab, met the primary endpoint in the treatment of patients with psoriatic arthritis (PsA), a progressive, chronic and destructive disease.
News
TetraLogic, Merck enter oncology clinical trial collaboration
By PBR Staff Writer
US-based biopharmaceutical firm TetraLogic Pharmaceuticals has entered into an oncology clinical study collaboration with Merck.
News